McGill University researcher Dr. Bernard Belleau developed antiviral drug 3TC (Lamivudine), a critical component of Hepatitis B and HIV therapies

, , ,

In 1989, McGill University researcher Dr. Bernard Belleau developed the antiviral drug 3TC (Lamivudine), which became a critical component of Hepatitis B and HIV therapies.

Tags:

,

Source: McGill University
Credit:

Visit News/History Source
bioinnovatise accelerates scientific discovery by providing fast, reliable, and high-quality CDMO services for plasmid DNA and viral vector-based research.